비교리스트

 카트 문의
시장보고서
상품코드
1472604

프로테오믹스 바이오마커 분석 시장 : 용도별, 기술별, 제품별, 장소별 예측 - 이그제큐티브 및 컨설턴트 가이드 첨부(2024-2028년)

Proteomic Biomarker Analytics Markets. Forecasts by Application, Technology, Product and Place. With Executive and Consultant Guides. 2024 to 2028
발행일: | 리서치사: Howe Sound Research | 페이지 정보: 영문 303 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 프로테오믹스 바이오마커 분석 시장에 대해 조사했으며, 시장의 개요와 용도별, 기술별, 제품별, 장소별 동향 및 시장에 참여하는 기업의 개요 등을 제공하고 있습니다.

목차

제1장 시장 가이드

제2장 서론과 시장의 정의

  • 프로테오믹스 바이오마커 분석이란 무엇인가?
  • 프로테오믹스와 의약품 개발
  • 시장의 정의
  • 조사 방법

제3장 프로테오믹스 바이오마커 분석 - 기술 가이드

  • 방법
    • 분리 기술과 전기영동
    • 질량분석
    • 크로마토그래피
    • 블로팅
    • 단백질 상보성 어세이와 상호작용 스크리닝
    • 단백질 구조 예측
    • 단백질 데이터베이스

제4장 업계의 개요

  • 시장 참여 조직
    • 학술연구기관
    • 진단 시험 개발자
    • 계측 공급업체
    • 약품·시약 제조업체
    • 병리 공급업체
    • 독립계 임상 검사실
    • 국립/지역 연구소
    • 병원 검사실
    • 임상 검사실
    • 감사 기관
    • 인증 기관

제5장 시장 동향

  • 성장 촉진요인
  • 성장 억제요인

제6장 프로테오믹스 바이오마커 분석의 최근 진보

제7장 프로테오믹스 바이오마커 분석의 주요 기업 개요

  • Abbott Laboratories
  • Abcam
  • Agilent
  • Amprion
  • ATUM
  • BasePair Biotechnologies
  • Beckman Coulter Diagnostics(Danaher)
  • Becton, Dickinson and Company
  • Biomatik
  • Bio-Rad Laboratories, Inc
  • Bio-Techne
  • Bruker
  • C2N Diagnostics
  • Cepheid(Danaher)
  • Diadem Diagnostics
  • Eve Technologies
  • Fujirebio
  • Hybrigenics Services
  • MRM Proteomics Inc.
  • NanoDx
  • Nautilus Biotechnology
  • Nicoya
  • Nuclera
  • Olink
  • Qiagen
  • Quanterix
  • Roche Diagnostics
  • Second Genome
  • Siemens Healthineers
  • Sphingotec
  • Thermo Fisher Scientific
  • Unchained Labs

제8장 세계의 프로테오믹스 바이오마커 분석 시장

  • 국가별 : 세계 시장 개요
  • 용도별 : 세계 시장 개요
  • 기술별 : 세계 시장 개요
  • 제품별 : 세계 시장 개요
  • 장소별 : 세계 시장 개요

제9장 세계의 프로테오믹스 바이오마커 분석 시장 : 용도별

  • Drug Discovery
  • 연구
  • 임상 진단
  • 기타

제10장 세계의 프로테오믹스 바이오마커 분석 시장 : 기술별

  • 질량분석
  • ELISA/비즈
  • 하이브리드 멀티플렉스
  • 기타

제11장 세계의 프로테오믹스 바이오마커 분석 시장 : 제품별

  • 기기
  • 키트와 시약
  • 서비스

제12장 세계의 프로테오믹스 바이오마커 분석 시장 : 장소별

  • 학술기관
  • 제약회사/바이오테크놀러지 기업
  • 임상
  • 기타

제13장 부록

KSA 24.05.13

OVERVIEW:

Where genomics can't find all the answers proteomics is stepping up to the plate.

Who will be the Illumina of Proteomics? Will these new biomarkers redefine disease definitions? Will Proteomic Assays displace current Genomic Assays? Find out all about it and more in this comprehensive report.

Proteomic Biomarker Analytics is just finding its feet, but the opportunity is huge. Players are reporting double digit growth. Venture capital is well involved. Learn about this market including the issues and outlooks. This technology could possibly displace most cancer diagnostic protocols AND save money at the same time. The report forecasts the market size out for five years for a number of different market segments.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

1. Market Guides

  • 1.1. Situation Analysis
  • 1.2. Guide for Executives and Marketing Staff
  • 1.3. Guide for Investment Analysts and Management Consultants

2. Introduction and Market Definition

  • 2.1. What is Proteomic Biomarker Analytics?
  • 2.2. Proteomics and Drug Development
  • 2.3. Market Definition
    • 2.3.1. Market Size
    • 2.3.2. Currency
    • 2.3.3. Years
  • 2.4. Methodology
    • 2.4.1. Methodology
    • 2.4.2. Sources
    • 2.4.3. Authors

3. Proteomic Biomarker Analytics-Guide to Technologies

  • 3.1. Methods
    • 3.1.1. Separation techniques and electrophoresis
    • 3.1.2. Mass spectrometry
    • 3.1.3. Chromatography
    • 3.1.4. Blotting
    • 3.1.5. Protein complementation assays and interaction screens
    • 3.1.6. Protein structure prediction
    • 3.1.7. Protein databases

4. Industry Overview

  • 4.1. Players in a Dynamic Market
  • 4.2. Academic Research Lab
  • 4.3. Diagnostic Test Developer
  • 4.4. Instrumentation Supplier
  • 4.5. Chemical/Reagent Supplier
  • 4.6. Pathology Supplier
  • 4.7. Independent Clinical Laboratory
  • 4.8. Public National/regional Laboratory
  • 4.9. Hospital Laboratory
  • 4.10. Physicians Office Lab (POLS)
  • 4.11. Audit Body
  • 4.12. Certification Body

5. Market Trends

  • 5.1. Factors Driving Growth
    • 5.1.1. Drug Development
    • 5.1.2. Companion Dx
    • 5.1.3. Fertile Research
    • 5.1.4. Technology Convergence
  • 5.2. Factors Limiting Growth
    • 5.2.1. The Cost Curve
    • 5.2.2. Capacity Constraints
    • 5.2.3. Market Lag

6. Proteomic Analytics Recent Developments

  • 6.1. Recent Developments-Importance and How to Use This Section
    • 6.1.1. Importance of These Developments
    • 6.1.2. How to Use This Section
  • 6.2. Mass Spec Test to Detect Ovarian Cancer
  • 6.3. Proteomic Multiple Sclerosis Test Gaining Traction
  • 6.4. Emory U Protein Panel Could Diagnose Alzheimer's Disease
  • 6.5. Amprion's Parkinson's Disease Dx Shows Strong Performance
  • 6.6. Single-Cell Proteomics Bypasses Bottlenecks
  • 6.7. SomaLogic Seeks 'Strategic Alternatives' for Dx Business
  • 6.8. Alzheimer's Dx Study to Add Genomic, Proteomic Profiling
  • 6.9. NanoDx Prepares for POC Platform Commercialization
  • 6.10. DeepMind AI Predicts 3D Structure of Every Protein
  • 6.11. Quanterix Slashing Workforce by 25 Percent
  • 6.12. Study Shows Potential of NanoMosaic's Platform for Biomarker Development
  • 6.13. Exact Sciences Bolsters Plasma Proteomics Tech With $15M Purchase of OmicEra
  • 6.14. PrognomiQ Exploring Multiomic Markers for Variety of Cancer Dx Applications
  • 6.15. Octave Bioscience Building Evidence Base for Multiple Sclerosis Test
  • 6.16. Proteomics Goes Public

7. Profiles of Key Proteomic Biomarker Analytic Companies

  • 7.1. Abbott Laboratories
  • 7.2. Abcam
  • 7.3. Agilent
  • 7.4. Amprion
  • 7.5. ATUM
  • 7.6. BasePair Biotechnologies
  • 7.7. Beckman Coulter Diagnostics (Danaher)
  • 7.8. Becton, Dickinson and Company
  • 7.9. Biomatik
  • 7.10. Bio-Rad Laboratories, Inc
  • 7.11. Bio-Techne
  • 7.12. Bruker
  • 7.13. C2N Diagnostics
  • 7.14. Cepheid (Danaher)
  • 7.15. Diadem Diagnostics
  • 7.16. Eve Technologies
  • 7.17. Fujirebio
  • 7.18. Hybrigenics Services
  • 7.19. MRM Proteomics Inc.
  • 7.20. NanoDx
  • 7.21. Nautilus Biotechnology
  • 7.22. Nicoya
  • 7.23. Nuclera
  • 7.24. Olink
  • 7.25. Qiagen
  • 7.26. Quanterix
  • 7.27. Roche Diagnostics
  • 7.28. Second Genome
  • 7.29. Siemens Healthineers
  • 7.30. Sphingotec
  • 7.31. Thermo Fisher Scientific
  • 7.32. Unchained Labs

8. Global Proteomic Analytics Markets

  • 8.1. PROTEIN ANALYTICS-Global Market Overview by Country
    • 8.1.1. Table-Global Market by Country
    • 8.1.2. Chart-Global Market by Country
  • 8.2. Global Market by Application-Overview
    • 8.2.1. Table-Global Market by Application
    • 8.2.2. Chart-Global Market by Application-Segments Growth
    • 8.2.3. Chart-Global Market by Application-Base/Final Comparison
    • 8.2.4. Chart-Global Market by Application-Base Year
    • 8.2.5. Chart-Global Market by Application-Final Year
    • 8.2.6. Chart-Global Market by Application-Share by Year
  • 8.3. Global Market by Technology-Overview
    • 8.3.1. Table-Global Market by Technology
    • 8.3.2. Chart-Global Market by Technology-Segments Growth
    • 8.3.3. Chart-Global Market by Technology-Base/Final Comparison
    • 8.3.4. Chart-Global Market by Technology-Base Year
    • 8.3.5. Chart-Global Market by Technology-Final Year
    • 8.3.6. Chart-Global Market by Technology-Share by Year
  • 8.4. Global Market by Product-Overview
    • 8.4.1. Table-Global Market by Product
    • 8.4.2. Chart-Global Market by Product-Segments Growth
    • 8.4.3. Chart-Global Market by Product-Base/Final Comparison
    • 8.4.4. Chart-Global Market by Product-Base Year
    • 8.4.5. Chart-Global Market by Product-Final Year
    • 8.4.6. Chart-Global Market by Product-Share by Year
  • 8.5. Global Market by Place-Overview
    • 8.5.1. Table-Global Market by Place
    • 8.5.2. Chart-Global Market by Place-Segments Growth
    • 8.5.3. Chart-Global Market by Place-Base/Final Comparison
    • 8.5.4. Chart-Global Market by Place-Base Year
    • 8.5.5. Chart-Global Market by Place-Final Year
    • 8.5.6. Chart-Global Market by Place-Share by Year

9. Global PROTEIN ANALYTICS Markets-By Application

  • 9.1. PROTEIN ANALYTICS Drug Discovery
    • 9.1.1. Table PROTEIN ANALYTICS Drug Discovery-by Country
    • 9.1.2. Chart-PROTEIN ANALYTICS Drug Discovery Growth
  • 9.2. PROTEIN ANALYTICS Research Application
    • 9.2.1. Table PROTEIN ANALYTICS Research Application-by Country
    • 9.2.2. Chart-PROTEIN ANALYTICS Research Application Growth
  • 9.3. PROTEIN ANALYTICS Clinical Dx
    • 9.3.1. Table PROTEIN ANALYTICS Clinical Dx-by Country
    • 9.3.2. Chart-PROTEIN ANALYTICS Clinical Dx Growth
  • 9.4. PROTEIN ANALYTICS Other Applications
    • 9.4.1. Table PROTEIN ANALYTICS Other Applications-by Country
    • 9.4.2. Chart-PROTEIN ANALYTICS Other Applications Growth

10. Global PROTEIN ANALYTICS Markets-By Technology

  • 10.1. PROTEIN ANALYTICS Mass Spectrometry
    • 10.1.1. Table PROTEIN ANALYTICS Mass Spectrometry-by Country
    • 10.1.2. Chart-PROTEIN ANALYTICS Mass Spectrometry Growth
  • 10.2. PROTEIN ANALYTICS ELISA/Beads
    • 10.2.1. Table PROTEIN ANALYTICS ELISA/Beads-by Country
    • 10.2.2. Chart-PROTEIN ANALYTICS ELISA/Beads Growth
  • 10.3. PROTEIN ANALYTICS Hybrid Multiplex
    • 10.3.1. Table PROTEIN ANALYTICS Hybrid Multiplex-by Country
    • 10.3.2. Chart-PROTEIN ANALYTICS Hybrid Multiplex Growth
  • 10.4. PROTEIN ANALYTICS Other Technology
    • 10.4.1. Table PROTEIN ANALYTICS Other Technology-by Country
    • 10.4.2. Chart-PROTEIN ANALYTICS Other Technology Growth

11. Global PROTEIN ANALYTICS Markets-By Product

  • 11.1. PROTEIN ANALYTICS Instruments
    • 11.1.1. Table PROTEIN ANALYTICS Instruments-by Country
    • 11.1.2. Chart-PROTEIN ANALYTICS Instruments Growth
  • 11.2. PROTEIN ANALYTICS Kits & Reagents
    • 11.2.1. Table PROTEIN ANALYTICS Kits & Reagents-by Country
    • 11.2.2. Chart-PROTEIN ANALYTICS Kits & Reagents Growth
  • 11.3. PROTEIN ANALYTICS Services
    • 11.3.1. Table PROTEIN ANALYTICS Services-by Country
    • 11.3.2. Chart-PROTEIN ANALYTICS Services Growth

12. Global PROTEIN ANALYTICS Markets-By Place

  • 12.1. PROTEIN ANALYTICS Academic
    • 12.1.1. Table PROTEIN ANALYTICS Academic-by Country
    • 12.1.2. Chart-PROTEIN ANALYTICS Academic Growth
  • 12.2. PROTEIN ANALYTICS Pharma/Biotech
    • 12.2.1. Table PROTEIN ANALYTICS Pharma/Biotech-by Country
    • 12.2.2. Chart-PROTEIN ANALYTICS Pharma/Biotech Growth
  • 12.3. PROTEIN ANALYTICS Clinical
    • 12.3.1. Table PROTEIN ANALYTICS Clinical-by Country
    • 12.3.2. Chart-PROTEIN ANALYTICS Clinical Growth
  • 12.4. PROTEIN ANALYTICS Other Place
    • 12.4.1. Table PROTEIN ANALYTICS Other Place-by Country
    • 12.4.2. Chart-PROTEIN ANALYTICS Other Place Growth

13. Appendices

  • 13.1. Clinical Laboratory Fee Schedule
  • 13.2. The Most Used IVD Assays
  • 13.3. The Highest Grossing Assays
  • 13.4. The Changing IVD Menu
    • 13.4.1. Approved IVD Test Menu History
  • 13.5. The Changing Picture on Reimbursement
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제